BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 25418416)

  • 1. Artemisinin resistance--modelling the potential human and economic costs.
    Lubell Y; Dondorp A; Guérin PJ; Drake T; Meek S; Ashley E; Day NP; White NJ; White LJ
    Malar J; 2014 Nov; 13():452. PubMed ID: 25418416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure.
    Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P
    BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring antimalarial drug efficacy in the Greater Mekong Subregion: an overview of in vivo results from 2008 to 2010.
    Bustos MD; Wongsrichanalai C; Delacollette C; Burkholder B
    Southeast Asian J Trop Med Public Health; 2013; 44 Suppl 1():201-30; discussion 306-7. PubMed ID: 24159833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost of treating inpatient falciparum malaria on the Thai-Myanmar border.
    Kyaw SS; Drake T; Ruangveerayuth R; Chierakul W; White NJ; Newton PN; Lubell Y
    Malar J; 2014 Oct; 13():416. PubMed ID: 25351915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined antimalarial therapy using artemisinin].
    Majori G
    Parassitologia; 2004 Jun; 46(1-2):85-7. PubMed ID: 15305693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of a policy change from single-agent treatment for suspected malaria to artesunate-amodiaquine for microscopically confirmed uncomplicated falciparum malaria in the Oussouye District of south-western Senegal.
    Agnamey P; Brasseur P; Cisse M; Gaye O; Dumoulin J; Rigal J; Taylor WR; Olliaro P
    Trop Med Int Health; 2005 Sep; 10(9):926-33. PubMed ID: 16135201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical impact of artemisinin resistance in Southeast Asia and the potential for future spread.
    Woodrow CJ; White NJ
    FEMS Microbiol Rev; 2017 Jan; 41(1):34-48. PubMed ID: 27613271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border.
    Phyo AP; Win KK; Thu AM; Swe LL; Htike H; Beau C; Sriprawat K; Winterberg M; Proux S; Imwong M; Ashley EA; Nosten F
    Malar J; 2018 Jan; 17(1):30. PubMed ID: 29334942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial Drug Resistance: A Threat to Malaria Elimination.
    Menard D; Dondorp A
    Cold Spring Harb Perspect Med; 2017 Jul; 7(7):. PubMed ID: 28289248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artemisinin resistance in Plasmodium falciparum: what is it really?
    Ferreira PE; Culleton R; Gil JP; Meshnick SR
    Trends Parasitol; 2013 Jul; 29(7):318-20. PubMed ID: 23768531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis, Treatment, and Prevention of Malaria in the US: A Review.
    Daily JP; Minuti A; Khan N
    JAMA; 2022 Aug; 328(5):460-471. PubMed ID: 35916842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Qinghaosu (artemisinin): the price of success.
    White NJ
    Science; 2008 Apr; 320(5874):330-4. PubMed ID: 18420924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
    van der Pluijm RW; Amaratunga C; Dhorda M; Dondorp AM
    Trends Parasitol; 2021 Jan; 37(1):15-24. PubMed ID: 33060063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Artemisinin-based combination treatment of falciparum malaria.
    Nosten F; White NJ
    Am J Trop Med Hyg; 2007 Dec; 77(6 Suppl):181-92. PubMed ID: 18165491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to Contain Artemisinin- and Multidrug-Resistant Falciparum Malaria.
    Dondorp AM; Smithuis FM; Woodrow C; Seidlein LV
    Trends Parasitol; 2017 May; 33(5):353-363. PubMed ID: 28187990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis.
    Kunkel A; White M; Piola P
    PLoS Comput Biol; 2021 Mar; 17(3):e1008850. PubMed ID: 33764971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
    Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
    Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness analysis of artesunate and quinine + tetracycline for the treatment of uncomplicated falciparum malaria in Chanthaburi, Thailand.
    Honrado ER; Fungladda W; Kamoiratanaku P; Kitayaporn D; Karbwang J; Thimasarn K; Masngammueng R
    Bull World Health Organ; 1999; 77(3):235-43. PubMed ID: 10212514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.